Mar 29, 2023 / 08:30PM GMT
Operator
Thank you for standing by, and welcome to Atreca's fourth-quarter and year-end 2022 earnings call. (Operator Instructions)
I would now like to hand the call over to Head of Investor Relations, Alex Gray. Please go ahead.
Alex Gray - Atreca, Inc. - Associate Director, Corporate Communications
Thank you, operator, and thank you to those joining us today. We are pleased to host our year-end 2022 conference call and webcast, including updated data from our ongoing Phase 1b trial of ATRC-101. Joining me for the prepared remarks are John Orwin, CEO; Dr. Tito Serafini, Chief Strategy Officer and Atreca Founder; Dr. Philippe Bishop, Chief Medical Officer; and Dr. Stephen Gould, Chief Scientific Officer. Also on the line is Herb Cross, Chief Financial Officer, who will be available during the Q&A session.
For those joining by phone, I'd note that we are presenting slides as part of today's program, which can be viewed via the webcast link included in our earnings release and posted to the Events and Presentations section of our Investor Relations
Q4 2022 Atreca Inc Earnings Call Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers